Biomarkers of Glioblastoma Multiforme Current update

Main Article Content

Guru Dutta Satyarthee
Luis Rafael Moscote-Salazar
Amit Agrawal

Abstract

Glioblastoma multiforme (G.B.M.) represents one of the commonest intracranial tumor associated with very poor prognosis. Despite recent advances in genomics and microneurosurgical techniques, chemotherapy regimens, radiation technology but despite of these mortality and morbidity still remains unacceptable very high. Various markers are utilized to stratify into different category in a desperate attempt to find out suitable therapeutic regimen to promote improved neurological outcome. Authors briefly reviews various biomarkers and utility in management of GBM.

Article Details

How to Cite
Satyarthee, G. D., Moscote-Salazar, L. R., & Agrawal, A. (2018). Biomarkers of Glioblastoma Multiforme: Current update. Romanian Neurosurgery, 32(3), 466-468. Retrieved from https://www.journals.lapub.co.uk/index.php/roneurosurgery/article/view/1116
Section
Articles
Author Biographies

Guru Dutta Satyarthee

Department of Neurosurgery, Neurosciences Centre, AIIMS New Delhi, INDIA

Luis Rafael Moscote-Salazar

Neurosurgeon-Critical Care, RED LATINO, Latin American Trauma & Intensive Neuro-Care Organization, Bogota, COLOMBIA

Amit Agrawal

Neurosurgery Department, Narayana Medical College Hospital, Chinthareddypalem, Nellore, Andhra Pradesh, INDIA